The tech-stock bubble starts to hiss air
America’s tech-heavy Nasdaq Composite index soared by more than 70% from the March low to the end of August, but September has brought a rare reversal.
America’s stockmarket rally could one day rank among history’s greatest bubbles, says Andrew Parlin in the Financial Times. Shares offering even “a whiff” of exposure to such fashionable areas as “the cloud, digital payments” and “plant-based food” have soared since the pandemic began. Just look at Tesla, whose market capitalisation has vaulted from $80bn in March to more than $300bn today.
Turning point or bump in the road?
America’s tech-heavy Nasdaq Composite index soared by more than 70% from the March low to the end of August, but September has brought a rare reversal. The index lost more than 10% between 2 September and Tuesday this week, officially entering “correction” territory.
This has had little impact on the year’s gains, but still wiped an extraordinary $320bn off the market capitalisation of Apple in just three trading days. The sell-off had no clear cause, although some blame Tesla’s rejection from the S&P 500, while others have pointed at SoftBank (see page 7).
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Market optimists say that pullbacks are normal in a healthy bull market, says Mark DeCambre for MarketWatch. The S&P 500 had its “strongest August in 34 years” so a “bout of profit-taking” was to be expected, says Mark Haefele of UBS Global Wealth Management.
Yet bears see growing risks. “September is a notoriously weak month for investors”. That is even more likely to be the case in 2020 owing to fears of an autumn coronavirus wave and US election uncertainty.
Bulls say that talk of rich valuations ignores the fact that profits this year have been poleaxed by the coronavirus, says Russ Mould of AJ Bell. If analysts’ predictions of a strong earnings rebound next year come true, then the S&P’s rating of 16.7 times 2021 earnings looks, if not exactly a bargain, then not entirely insane either.
A debt-fuelled bubble
It is difficult to overstate the extent to which the US market rebound has depended on the technology giants. If you exclude Facebook, Apple, Amazon, Google, Netflix and Microsoft, the “S&P 500’s market cap is less than 1% higher than it was in January 2018”, says Mould.
The stock rally is also underpinned by debt, says Randall Forsyth in Barron’s. US federal debt will soon surpass 100% of GDP. Emergency spending in hard times is one thing, but America’s budget deficit was running at nearly 5% of GDP before anyone had heard of Covid-19.
The “debt binge” also extends to the private sector thanks to the Federal Reserve’s “whatever it takes” approach to stimulus, adds Michael Mackenzie in the Financial Times. From Japan’s 1980s asset bubble to the 1990s Asian financial crisis, history shows that easy money binges can leave assets “languishing” for years after the bubble pops.
Japanese equities have yet to regain their 1989 peak. Bulls beware: share prices juiced by unprecedented fiscal and monetary stimulus might finally be “hitting their limits”.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
8 of the best properties for sale with indoor swimming pools
The best properties for sale with indoor swimming pools – from an award-winning contemporary house in East Sussex, to a converted barn in Hampshire
By Natasha Langan Published
-
Chinese stocks slump on first trading day of 2025
Chinese stocks suffered in the new year from their worst first day of trading since 2016, despite a state stimulus package
By Alex Rankine Published
-
Why Wise could be worth a lot more than its share price implies
Foreign-exchange transfer service Wise has the potential to become the Amazon of its sector – here's why you should consider buying this stock now
By Jamie Ward Published
-
Can The Gym Group pump up your portfolio?
Gym Group was one of the best UK small-cap stocks in 2024 and will beef up your profits this New Year
By Rupert Hargreaves Published
-
MoneyWeek's five predictions for investors in 2025
MoneyWeek's City columnist gazes into his crystal ball and sees five unexpected events in store for investors in 2025
By Matthew Lynn Published
-
How buy-and-build stocks deliver strong returns
Bunzl, DCC and Diploma became successful through buy-and-build – rolling up dozens of unglamorous businesses. How does it work and what makes it successful?
By Jamie Ward Published
-
Singapore Technologies Engineering shows strong growth
Singapore Technologies Engineering offers diversification, improving profitability and income
By Dr Mike Tubbs Published
-
Royal Mail takeover by Czech billionaire approved for £3.6bn
Royal Mail is now owned by Czech billionaire Daniel Kretinsky, following a £3.6 billion takeover
By Dr Matthew Partridge Published
-
Will AI be the future of advertising?
It remains to be seen, but the idea that AI providers can make money from advertising does not bode well
By Matthew Lynn Published
-
AstraZeneca goes cheap – should you buy?
The decline in AstraZeneca’s share price is overdone given the outlook, and the stock is cheap
By Rupert Hargreaves Published